Current market catalysts

Bronstein, Gewirtz & Grossman LLC Urges EquipmentShare.com Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against EquipmentShare.com Inc. (NASDAQ: EQPT) alleging that the company and its officers made materially false statements and failed to disclose undisclosed related-party transactions with entities owned by co-founders. The complaint claims the company's financial statements were misleading regarding these transactions. Investors who purchased securities during the IPO on January 23, 2026, or between January 23 and June 23, 2026, are eligible to join the case, with a lead plaintiff deadline of September 21, 2026.

Bronstein, Gewirtz & Grossman LLC Urges Fractyl Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Fractyl Health, Inc. (NASDAQ: GUTS) alleging that company executives made materially false and misleading statements regarding the effectiveness of its Revita product and the integrity of clinical trial results. The lawsuit covers investors who purchased Fractyl securities between January 13, 2025 and January 29, 2026. The lead plaintiff deadline is October 20, 2026.

Bronstein, Gewirtz & Grossman LLC Urges Intuit Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Intuit Inc. alleging that the company made materially false and misleading statements regarding its business operations and prospects during the period from August 22, 2025 to May 20, 2026. The complaint claims Intuit overstated its competitive advantages and growth while concealing significant business losses in its TurboTax division due to competitive and pricing pressures, rendering its FY 2026 revenue guidance unreliable.

Why Intel Stock Rallied Tuesday Morning

Intel stock surged 8-9% on reports of planned 10% CPU price increases aimed at improving gross margins. Northland Securities upgraded Intel to 'outperform' with a $120 price target, citing material progress in the company's turnaround and foundry ambitions. However, analysts note the stock is already expensive at 68x forward earnings.

Why D-Wave Quantum Stock Popped Today

D-Wave Quantum received up to $100 million in funding from the U.S. Department of Commerce under the CHIPS and Science Act, causing its stock to rise 10.86%. However, the government also awarded similar $100 million grants to rival quantum companies Quantinuum and Rigetti Computing. GlobalFoundries received the largest award at $375 million, suggesting it may be the government's preferred champion rather than D-Wave.

History Shows the Investors Who Make This 1 Move During Bear Markets Build the Most Wealth

The article argues that investors who aggressively buy during bear markets, rather than panic selling, build significantly more wealth over time. Using Warren Buffett's philosophy of maintaining cash reserves to deploy during market downturns, the piece demonstrates that a modest improvement in annual returns (from 10% to 11%) through strategic bear market investing could result in approximately one-third more wealth over 30 years. The key is maintaining discipline and a long-term perspective rather than attempting to time market peaks and troughs perfectly.

If I Could Invest $500 in Just 1 ETF in September, Here's What I'd Buy

A Motley Fool analyst recommends the Vanguard Total International Stock ETF (VXUS) as a single $500 investment choice for September 2026, citing concerns about S&P 500 valuations driven by AI stocks. VXUS has delivered 26% returns over the past year and 19.8% annualized returns over three years. Vanguard research forecasts international stocks may outperform U.S. stocks by 1.2-2.2% annually over the next 30 years.

Bronstein, Gewirtz & Grossman LLC Urges Papa John's International, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Papa John's International, Inc. (NASDAQ: PZZA) alleging securities fraud. The complaint claims that company executives made materially false and misleading statements regarding the company's transformation efforts, market share losses, and competitive position during the period from August 7, 2025 to August 5, 2026. Investors who purchased Papa John's securities during this period are encouraged to join the case, with a lead plaintiff deadline of November 2, 2026.

Bronstein, Gewirtz & Grossman LLC Urges iTonic Holdings Ltd. f/k/a Pheton Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against iTonic Holdings Ltd. (formerly Pheton Holdings Ltd.) alleging that the company made materially false and misleading statements regarding market manipulation schemes, fraudulent trading activity, and stock price inflation. The lawsuit covers investors who purchased shares between September 5, 2024 and July 29, 2025. The lead plaintiff deadline is September 29, 2026.

US Strategic Petroleum Reserve Crude Stocks Fall About 1.2M Barrels To 285.4M Barrels, Lowest Since 1982

Citigroup Initiates Coverage On UiPath with Buy Rating, Announces Price Target of $23

Citigroup analyst Yitchuin Wong initiates coverage on UiPath (NYSE:PATH) with a Buy rating and announces Price Target of $23.

8-K filing — Federal Home Loan Bank of Cincinnati

Filed: 2026-09-08 AccNo: 0001326771-26-000145 Size: 456 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Citigroup Upgrades Old Dominion Freight Line to Buy, Lowers Price Target to $223

Citigroup analyst Ariel Rosa upgrades Old Dominion Freight Line (NASDAQ:ODFL) from Neutral to Buy and lowers the price target from $231 to $223.

Citigroup Upgrades C.H. Robinson Worldwide to Buy, Lowers Price Target to $185

Citigroup analyst Ariel Rosa upgrades C.H. Robinson Worldwide (NASDAQ:CHRW) from Neutral to Buy and lowers the price target from $196 to $185.

Shares of medical device-related companies are trading lower amid possible sympathy with Boston Scientific after that company announced it was likely to miss its FY26 and Q3 adjusted EPS and net sales growth guidance following a previously announced cybersecurity incident that affected operations.

Why Guidewire Stock Dropped After Reporting An Upbeat Quarter

The Guidewire stock drop hit 20% after a Q4 earnings beat. See why soft FY27 guidance and a stretched valuation triggered the sell-off.

Citigroup Initiates Coverage On Arrowhead Pharma with Buy Rating, Announces Price Target of $108

Citigroup analyst Eric Joseph initiates coverage on Arrowhead Pharma (NASDAQ:ARWR) with a Buy rating and announces Price Target of $108.

8-K filing — iQSTEL Inc (IQST)

Filed: 2026-09-08 AccNo: 0001663577-26-000262 Size: 280 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Netflix Faces South Africa Price Probe, Putting Stock Under Pressure

Crude Oil Gains 1.5%; ABM Posts Upbeat Q3 Earnings

Ladenburg Thalmann Initiates Coverage On Evolv Technologies with Buy Rating, Announces Price Target of $8

If You Invested $1000 In Thermo Fisher Scientific Stock 15 Years Ago, You Would Have This Much Today

Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 15 years by 4.35% on an annualized basis producing an average annual return of 17.57%. Currently, Thermo Fisher Scientific has a market

Robinhood Expands Prediction Markets Push With Crypto.com, OG Deal

Robinhood strikes a multiyear Crypto.com deal to add OG contracts and take minority stakes as its prediction-market business keeps growing.

Qualcomm CFO Says Deal With Amazon Positions Qualcomm To Deliver Strong YoY Rev Growth From FY27 To FY28

HC Wainwright & Co. Reiterates Buy on Adlai Nortye, Maintains $20 Price Target

Ladenburg Thalmann Initiates Coverage On Hawaiian Electric Indus with Sell Rating, Announces Price Target of $7

HC Wainwright & Co. Reiterates Buy on Generate Biomedicines, Maintains $30 Price Target

TeraWulf shares are trading higher after Freedom Capital initiated coverage on the stock with a Buy rating and announced a $19 price target.

HC Wainwright & Co. Reiterates Buy on Pharvaris, Maintains $60 Price Target

HSBC Reiterates Buy on Apple, Maintains $366 Price Target